Roche Holding AG (OTCQX International Premier:RHHBF)

417.00
Delayed Data
As of Sep 17
 +5.00 / +1.21%
Today’s Change
320.00
Today|||52-Week Range
473.50
+17.76%
Year-to-Date
With Prothena Up Over 500% This Year, Is It Too Late to Get in?
Sep 18 / MotleyFool.com - Paid Partner Content
Celldex (CLDX) Initiates Subcutaneous Skin Disorder Drug Study
Sep 14 / Zacks.com - Paid Partner Content
Why Adaptimmune Therapeutics Was Sinking This Week
Sep 17 / MotleyFool.com - Paid Partner Content
Eyes Have It in AbbVie Deal With Regenxbio
Sep 13 / GuruFocus News - Paid Partner Content
Alzheimer's Drug for Roche Partner AC Immune Shows Promise
Sep 16 / GuruFocus News - Paid Partner Content
Why MacroGenics Soared Nearly 9% Higher Today
Sep 09 / MotleyFool.com - Paid Partner Content
Regeneron, Lilly Get New COVID Drug Deals From Government
Sep 16 / Zacks.com - Paid Partner Content
Adaptimmune (ADAP) Gains on Deal With Roche for Cell Therapies
Sep 08 / Zacks.com - Paid Partner Content
OPKO Health (OPK) Forms JV, Establishes Presence in China
Sep 15 / Zacks.com - Paid Partner Content
2 Stocks I Bought Last Week
Sep 08 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close412.00
Today’s open418.00
Day’s range411.16 - 418.00
Volume26
Average volume (3 months)105
Market cap$66.7B
Data as of 09/17/2021

Growth & Valuation

Earnings growth (last year)+12.27%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+0.46%
P/E ratio--
Price/Sales4.88
Price/Book8.65

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$62.1B
Annual profit (last year)$15.2B
Net profit margin24.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts

Chart unavailable